Dermatol. praxi. 2011;5(3):167-169

Melasma: aetiology and treatment options

MUDr.Ivana Plecháčová1, MUDr.Lukáš Lacina, Ph.D.2
1 Lasermed &ndash, Centrum preventivní a estetické dermatologie, s. r. o., Praha
2 Dermatovenerologická klinika 1. LF UK Praha

Pigmentation disorders, particularly in the facial area, are among major psychosocial problems the management of which is often

provided by a dermatologist. These disorders may adversely affect the patient’s quality of life. Differential diagnosis involves a rather

large number of conditions that may result in pigmentation changes. In addition to locally-acting factors, inborn errors, manifestations

of systemic disease, or effects of medication use all have to be considered. The paper provides a brief overview of issues concerning

melasma and its treatment options.

Keywords: hyperpigmentation, melasma, hormones, UV light, therapy

Published: November 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Plecháčová I, Lacina L. Melasma: aetiology and treatment options. Dermatol. praxi. 2011;5(3):167-169.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Miot LD, Miot HA, Silva MG, et al. Physiopathology of melasma. An Bras Dermatol 2009; 84(6): 623-635. Go to original source... Go to PubMed...
    2. Ortonne JP, Arellano I, Berneburg M, et al. A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma. J Eur Acad Dermatol Venereol 2009; 23(11): 1254-1262. Go to original source... Go to PubMed...
    3. Kang WH, Yoon KH, Lee ES, et al. Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol 2002; 146(2): 228-237. Go to original source... Go to PubMed...
    4. Gupta AK, Gover MD, Nouri K, et al. The treatment of melasma: a review of clinical trials. J Am Acad Dermatol 2006; 55(6): 1048-1065. Go to original source... Go to PubMed...
    5. Kang HY, Ortonne JP. What should be considered in treatment of melasma. Ann Dermatol 2010; 22(4): 373-378. Go to original source... Go to PubMed...
    6. Majid I. Mometasone-based triple combination therapy in melasma: is it really safe? Indian J Dermatol 2010; 55(4): 359-362. Go to original source... Go to PubMed...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.